Contact
Please use this form to send email to PR contact of this press release:
Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its COVID-19 Booster Vaccine Candidate
TO:
Please use this form to send email to PR contact of this press release:
Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its COVID-19 Booster Vaccine Candidate
TO: